Apr 22 |
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
|
Apr 22 |
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
|
Apr 16 |
Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
|
Apr 2 |
What Makes Veracyte (VCYT) a Lucrative Investment?
|
Feb 29 |
Veracyte files automatic mixed securities shelf
|
Feb 29 |
Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
|
Feb 28 |
Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
|
Feb 27 |
Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
|
Feb 27 |
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
|
Feb 26 |
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
|